SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) Antikörper

Produktnummer ABIN6952555

Dieses Maus Monoklonal-Antikörper erkennt spezifisch in ELISA, WB und IF. Er zeigt eine Reaktivität gegenüber SARS Coronavirus (SARS-CoV).

Kurzübersicht für SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) Antikörper (ABIN6952555)

Target: SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)

Reaktivität: SARS Coronavirus (SARS-CoV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: ELISA, Western Blotting (WB), Immunofluorescence (IF)

Klon: M88095

Produktdetails

Verwendungszweck: Mouse monoclonal SARS Coronavirus antibody

Spezifität: This antibody recognizes the nucleoprotein of the SARS virus

Aufreinigung: Protein A chromatography purified IgG fraction

Reinheit: > 90 %

Immunogen: SARS coronavirus antibody was raised in mouse using nucleoprotein of the SARS virus as the immunogen.

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

This SARS-CoV Nucleocapside antibody reacts with SARS-CoV protein (ABIN6952561).

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 10 mM PBS, pH 7.4 with 0.1 % Sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: -20°C

Antigendetails

Target: SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)

Andere Bezeichnung: SARS-Coronavirus Nucleocapsid Protein

Substanzklasse: Viral Protein

Hintergrund: The SARS coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS). On April 16, 2003, following the outbreak of SARS in Asia and secondary cases elsewhere in the world, the World Health Organization (WHO) issued a press release stating that the coronavirus identified by a number of laboratories was the official cause of SARS. Samples of the virus are being held in laboratories in New York, San Francisco, Manila, Hong Kong, and Toronto.